Table 1. Highly notable events in the applied rabies field related to detection, prevention, and control over the past decade.

Item	Reference
Discovery of new lyssavirus species	4
Suggestion of rabies virus adaptation beyond carnivores and bats to other mammals, such as non-human primates	5
Greater appreciation of wildlife reservoirs in previously considered “rabies-free” areas	6
Recognition of additional antigen detection, serological, and molecular tests for very sensitive and specific lyssavirus diagnosis	7
Recognizable shifts from animal culling to mass dog vaccination as a proven management strategy	8
Planning for the global elimination of human rabies mediated via dogs by 2030	9
Greater focus upon local infiltration of wounds with scarce rabies immunoglobulins	10
Availability of human monoclonal antibodies as an alternative to polyclonal rabies immunoglobulin	11
Recommendations on dose-sparing and shorter 1 week human prophylaxis regimens	12
Expansion of the distribution of vampire bats and rabies virus spread	13,197
Support for pre-exposure vaccination for those in remote settings, such as children in communities with a high exposure rate to canine rabies virus and those at risk of vampire bat depredation	14
In vitro alternatives to animal testing in the determination of vaccine potency	15
Demonstration of compounds with repeatable in vitro anti-rabies virus activity	16
Renewal of interest for the oral vaccination of free-ranging dogs against rabies	17
Elimination of canine rabies in Mexico	18
Expectations of Gavi support for human rabies vaccination	19